Verona Pharma Plc ADR’s recently made public that its General Counsel Fisher Andrew unloaded Company’s shares for reported $0.92 million on Jun 16 ’25. In the deal valued at $11.53 per share,80,000 shares were sold. As a result of this transaction, Fisher Andrew now holds 359,999 shares worth roughly $34.94 million.
Then, Hahn Mark W sold 400,000 shares, generating $4,560,360 in total proceeds. Upon selling the shares at $11.40, the Chief Financial Officer now owns 12,278,992 shares.
Before that, ZACCARDELLI DAVID sold 400,000 shares. Verona Pharma Plc ADR shares valued at $4,560,520 were divested by the President and CEO at a price of $11.40 per share. As a result of the transaction, ZACCARDELLI DAVID now holds 13,190,168 shares, worth roughly $1.28 billion.
TD Cowen initiated its Verona Pharma Plc ADR [VRNA] rating to a Buy in a research note published on April 28, 2025; the price target was $100. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. ROTH MKM began covering VRNA with “Buy” recommendation on January 10, 2025. Wells Fargo started covering the stock on October 03, 2024. It rated VRNA as “an Overweight”.
Price Performance Review of VRNA
On Monday, Verona Pharma Plc ADR [NASDAQ:VRNA] saw its stock jump 2.89%% to $97.05. Over the last five days, the stock has gained 5.26%. Verona Pharma Plc ADR shares have risen nearly 526.13% since the year began. Nevertheless, the stocks have risen 108.98% over the past one year. While a 52-week high of $94.45 was reached on 06/23/25, a 52-week low of $14.14 was recorded on 01/10/25.
Levels Of Support And Resistance For VRNA Stock
The 24-hour chart illustrates a support level at 95.08, which if violated will result in even more drops to 93.12. On the upside, there is a resistance level at 98.09. A further resistance level may holdings at 99.14.
How much short interest is there in Verona Pharma Plc ADR?
A steep rise in short interest was recorded in Verona Pharma Plc ADR stocks on 2025-05-30, dropping by -0.87 million shares to a total of 7.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 8.0 million shares. There was a decline of -12.15%, which implies that there is a negative sentiment for the stock.
